echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Int J Dermatol: Melanoma survivors are at increased risk of developing a second primary keratinocarcinoma

    Int J Dermatol: Melanoma survivors are at increased risk of developing a second primary keratinocarcinoma

    • Last Update: 2022-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Melanoma is one of
    the most commonly diagnosed cancers worldwide.
    A recent large cohort report shows that melanoma survivors are at risk
    of developing a second form of keratinocarcinoma (KC).
    However, the detailed proportions and risks remain unknown
    .
    Given the socioeconomic burden and mortality associated with a second KC, determining the detailed risk of a second primary BCC or SCC after initial melanoma treatment is critical
    to inform long-term outcomes and design follow-up protocols.
    A meta-analysis published today in Int J Dermatol aims to comprehensively analyze the risk of
    developing keratinocarcinoma after primary melanoma.

    The researchers searched PubMed, Embase, Web of Science, and Cochrane libraries for articles
    included before September 13, 2021.
    Pooled proportions and standardised incidence rates (SIRs) and their corresponding 95% confidence intervals (CI) were pooled to assess risk
    .

     

    As a result, 15 studies covering 168,286 patients
    were included.
    The proportion of melanoma survivors who developed basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and KC after pooling was 4.
    11% (95% CI, 1.
    32 to 6.
    90), 2.
    54% (95% CI, 1.
    78 to 3.
    31), and 5.
    45% (95% CI, 3.
    06 to 7.
    84),
    respectively 。 The analysis showed that melanoma survivors had a 5.
    3-fold increased risk of developing a second BCC, SCC, and KC compared with the general population (SIR 5.
    30; 95% CI, 4.
    87-5.
    77), 2.
    6-fold (SIR 2.
    58; 95% CI, 1.
    33-5.
    04), and 6.
    2-fold (SIR 6.
    17; 95% CI, 3.
    66-10.
    39),
    respectively.
    In meta-analyses, both fixed-effect and random-effects models were applied and consistent conclusions
    were drawn.

    Taken together, the findings suggest that melanoma survivors are at higher risk of developing a second primary BCC and SCC, suggesting the significance of monitoring and preventing a second primary KC in patients with a history of
    melanoma.
    Further research is needed to elucidate the carcinogenic mechanisms in melanoma patients and to optimize screening guidelines for early detection and prevention of subsequent KC
    .

     

    Original source:

     

    Huiyan Sun, et al.
    , Melanoma survivors are at increased risk for second primary keratinocyte carcinoma.
    Int J Dermatol.
    2022 Nov; 61(11):1397-1404.
    doi: 10.
    1111/ijd.
    16309.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.